Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8668366 | Journal of Clinical Lipidology | 2018 | 29 Pages |
Abstract
LDL-Ccorr is lower than laboratory “LDL-C” in patients with elevated Lp(a). Following apolipoprotein(a) inhibition and decline in Lp(a) and Lp(a)-C, the decline in apoB-100 is consistent with the notion that LDL devoid of apo(a) is cleared faster than Lp(a). These types of analyses may provide insights into the mechanisms of drugs affecting Lp(a) levels in clinical trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nicholas J. BSc, Calvin MD, PhD, Xiaohong BS, Shuting MS, Joseph L. MD, Sotirios MD,